FREDEX LIMITED
Company number 15047074 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
FREDEX LIMITED - Analysis Report
Company Number: 15047074
Analysis Date: 2025-07-29 14:16 UTC
Financial Health Assessment: FREDEX LIMITED (as of 30 June 2024)
1. Financial Health Score: C
Explanation:
FREDEX LIMITED is a newly incorporated micro-entity with modest financial scale and limited historical data. The company shows signs of early-stage operational activity but exhibits some mild financial stress indicators, particularly in working capital management. The score "C" reflects a company that is currently functioning but requires close monitoring and management attention to improve its financial robustness.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Share Capital | 110 | Minimal equity base, typical for a newly formed micro company. |
| Fixed Assets | 6,261 | Modest investment in long-term assets; indicates some capital expenditure. |
| Current Assets | 44,960 | Represents liquid or near-liquid resources; relatively healthy cash-like assets for operations. |
| Current Liabilities | 49,407 | Short-term debts slightly exceed current assets, indicating a working capital deficit. |
| Net Current Assets | -4,447 | Negative working capital suggests short-term liquidity pressure ("symptom of distress"). |
| Accruals and Deferred Income | 1,495 | Obligations recognized but not yet paid; adds to short-term liabilities. |
| Net Assets / Shareholders Funds | 319 | Positive but very low equity, indicating limited buffer for absorbing losses. |
| Employees | 3 | Small team, consistent with micro-entity status and early business stage. |
3. Diagnosis
"Symptoms Analysis":
- The company is in its infancy (incorporated August 2023), so financial statements cover less than a full operational year, limiting trend analysis.
- A negative net current assets position (-£4,447) signals a working capital deficiency, meaning the company may face challenges meeting short-term obligations without additional cash inflow or financing. This is akin to a patient showing signs of dehydration—manageable but requiring intervention to restore balance.
- The positive but minimal net assets (£319) and shareholders funds reflect a very thin equity cushion. This limited capital base restricts the company’s ability to absorb operational shocks or invest in growth without external support.
- The small fixed asset base and workforce size align with a micro-entity operating at a modest scale.
- No long-term liabilities or provisions suggest no significant debt burden beyond short-term creditors. This is a positive sign akin to a patient without chronic underlying conditions.
- The company's exemption from audit under the small companies regime means fewer checks but also less detailed financial oversight.
Overall Financial Condition:
FREDEX LIMITED is operational but currently experiences early-stage financial "symptoms" typical of startup or micro-entities: tight liquidity and minimal equity buffer. This is a common scenario where survival depends on managing cash flow carefully and building financial reserves.
4. Recommendations
To improve financial wellness and avoid potential "financial illness," the company should consider:
Improve Working Capital Management:
- Accelerate collection of receivables and negotiate longer payment terms with suppliers to reduce current liabilities pressure.
- Monitor cash flow forecasts rigorously to anticipate liquidity needs and avoid shortfalls.
Strengthen Equity Base:
- Consider capital injections from shareholders or external investors to build a stronger equity buffer.
- Retain profits within the business to grow reserves over time.
Control Costs:
- Keep operating expenses tight, especially with a small team, to avoid eroding limited capital resources.
Plan for Growth Prudently:
- Avoid overcommitting to asset purchases or hiring until cash flow stabilizes.
- Evaluate financing options such as short-term credit facilities only if cost-effective.
Regular Financial Monitoring:
- Maintain up-to-date financial records and perform monthly reviews of key metrics to catch "symptoms" early.
Compliance and Reporting:
- Ensure timely filing of accounts and confirmation statements to maintain good standing and avoid penalties.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.